Report Detail
Aortic Aneurysm Repair Devices Global Market – Forecast To 2023
- RnM3925059 |
- 12 March, 2020 |
- Global |
- 341 Pages |
- IQ4I Research & Consultancy |
- Medical Devices & Consumables
An aneurysm develops due to the weakening of blood vessel which results in a balloon-like dilation. Aneurysms can occur in any artery, it happens most often in the abdominal aorta, an essential blood vessel that supplies blood to legs. Most aortic aneurysms occur in the section of the aorta that passes through the abdomen and are referred as abdominal aortic aneurysms, sometimes in the chest referred as thoracic aortic aneurysms. Normally the diameter of the aorta in the abdomen is about 2 cm but in the case of an abdominal aortic aneurysm, the diameter increases to 3 cm or even more. Once an aortic aneurysm develops gradually it tends to become larger and the speed at which it becomes larger varies from person to person. Generally, aneurysm tends to become larger by about 10% per year. This condition rarely happens in the age group below 60 years. The wall of the aorta normally has layers of elastin, collagen and smooth muscle tissue. As people grow older aorta loses its normal strength and elasticity due to changes in the elastin, collagen and smooth muscle tissues. Genetic makeup also plays a major part in the development of aortic aneurysms. The condition can be treated by either open surgery or by EVAR procedure. EVAR is a minimally-invasive newer technique which employs stent grafts and other components like catheter, guide wires and other devices to repair an aortic aneurysm and has become a popular option in recent years.
The Aortic aneurysm Repair Devices global market is expected to grow at mid range single digit CAGR to reach $3,448.2 million by 2023. The Aortic Aneurysm Repair Devices market is classified based on site, product, repair type and geography. The Aortic Aneurysm Repair Devices products market is divided into Stent grafts, Catheters, and Others. The Aortic Aneurysm Repair Devices by site market is segmented into Abdominal Aortic Aneurysm (AAA) and Thoracic Aortic Aneurysm (TAA). Abdominal aortic aneurysm market is further segmented into Infrarenal and Perarenal. The perarenal market is further sub-segmented into Juxtrarenal and Suprarenal. Thoracic Aortic Aneurysm market is divided into Ascending an aortic aneurysm, Descending aortic aneurysm, Thoracoabdominal Aortic Aneurysm (TAAA) and Thoracic Arch Aneurysm. The Aortic Aneurysm market by repair type is divided into Abdominal Aortic Aneurysm (AAA) and Thoracic Aortic Aneurysm (TAA). Abdominal aortic aneurysm is divided into open surgery and Endovascular aneurysm repair (EVAR). Thoracic aortic aneurysm repair is divided into open surgery and Thoracic endovascular aneurysm repair (TEVAR).
Further, the Aortic Aneurysm Repair Devices market is separated by geographical regions into North America, Europe, Asia-pacific and Rest of the World.
1 EXECUTIVE SUMMARY 22
2 INTRODUCTION 33
- 2.1 KEY TAKE AWAYS 33
- 2.2 REPORT DESCRIPTION 33
- 2.3 MARKETS COVERED 34
- 2.4 STAKEHOLDERS 36
- 2.5 RESEARCH METHODOLOGY 36
- 2.5.1 MARKET SIZE ESTIMATION 38
- 2.5.2 MARKET CRACKDOWN AND DATA TRIANGULATION 41
- 2.5.3 SECONDARY SOURCES 42
- 2.5.4 PRIMARY SOURCES 42
- 2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES 43
- 2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES 43
- 2.5.7 ASSUMPTIONS 44
3 MARKET ANALYSIS 46
- 3.1 INTRODUCTION 46
- 3.2 MARKET SEGMENTATION 47
- 3.3 FACTORS INFLUENCING MARKET 49
- 3.3.1 DRIVERS AND OPPORTUNITIES 49
- 3.3.1.1 Rising geriatric population 49
- 3.3.1.2 Increasing prevalence of lifestyle diseases 50
- 3.3.1.3 Growing acceptance for minimally invasive endovascular surgeries 51
- 3.3.1.4 Technological advancements in evar 52
- 3.3.1.5 Mergers and acquisitions 53
- 3.3.1.6 Market expansion opportunities in emerging nations 54
- 3.3.2 RESTRAINTS AND THREATS 54
- 3.3.2.1 Risks associated with endovascular procedures such as endoleaks and
radiation exposure 54
- 3.3.2.2 High costs of an endovascular aneurysm repair procedures 55
- 3.3.2.3 Stringent regulatory approval requirement for an aortic aneurysm
- 3.3.1 DRIVERS AND OPPORTUNITIES 49
repair product 56
- 3.3.2.4 Lack of skilled professionals 57
- 3.3.2.5 Challenges associated with repair of complex anatomies 58
- 3.3.2.6 Off-the-shelf stent grafts in treating complex anatomies 58
- 3.4.1 U.S. 59
- 3.4.2 EUROPE 60
- 3.4.3 INDIA 60
- 3.4.4 CHINA 61
- 3.4.5 JAPAN 61
- 3.5.1 REIMBURSEMENT TABLE 63
- 3.6.1 THREAT OF NEW ENTRANTS 69
- 3.6.2 THREAT OF SUBSTITUTES 70
- 3.6.3 BARGAINING POWER OF SUPPLIERS 71
- 3.6.4 BARGAINING POWER OF BUYERS 72
- 3.6.5 COMPETITIVE RIVALRY 72
- 3.7.1 AORTIC ANEURYSM REPAIR DEVICES GLOBAL MARKET SHARE
ANALYSIS, BY MAJOR PLAYERS 73
- 3.7.2 EVAR GLOBAL MARKET SHARE ANALYSIS, BY MAJOR PLAYERS 76
- 3.7.3 TEVAR GLOBAL MARKET SHARE ANALYSIS, BY MAJOR PLAYERS 78
- 3.7.4 U.S. EVAR MARKET SHARE ANALYSIS, BY MAJOR PLAYERS 80
- 3.7.5 EUROPE EVAR MARKET SHARE ANALYSIS, BY MAJOR PLAYERS 82
- 3.7.6 JAPAN EVAR MARKET SHARE ANALYSIS, BY MAJOR PLAYERS 84
4 AORTIC ANEURYSM REPAIR DEVICES GLOBAL MARKET, BY SITE 88
- 4.1 INTRODUCTION 88
- 4.2 ABDOMINAL AORTIC ANEURYSM 91
- 4.2.1 INFRARENAL 96
- 4.2.2 PERARENAL 99
- 4.2.2.1 Juxtrarenal aortic aneurysm 101
- 4.2.2.2 Suprarenal aortic aneurysm 102
- 4.3 THORACIC AORTIC ANEURYSM 103
- 4.3.1 ASCENDING THORACIC AORTIC ANEURYSM 107
- 4.3.2 DESCENDING THORACIC AORTIC ANEURYSM 108
- 4.3.3 THORACOABDOMINAL AORTIC ANEURYSM 110
- 4.3.4 THORACIC ARCH ANEURYSM 112
5 AORTIC ANEURYSM REPAIR DEVICES GLOBAL MARKET, BY PRODUCT 115
- 5.1 INTRODUCTION 115
- 5.2 STENT GRAFTS 118
- 5.3 CATHETERS 122
- 5.4 OTHERS 125
6 AORTIC ANEURYSM GLOBAL MARKET, BY REPAIR TYPE 128
- 6.1 INTRODUCTION 128
- 6.2 ABDOMINAL AORTIC ANEURYSM (AAA) REPAIR 131
- 6.2.1 OPEN REPAIR 137
- 6.2.2 ENDOVASCULAR ANEURYSM REPAIR (EVAR) 139
- 6.3 THORACIC AORTIC ANEURYSM (TAA) REPAIR 143
- 6.3.1 OPEN REPAIR 149
- 6.3.2 THORACIC ENDOVASCULAR ANEURYSM REPAIR (TEVAR) 152
7 AORTIC ANEURYSM REPAIR DEVICES GLOBAL MARKET, BY REGION 155
- 7.1 INTRODUCTION 155
- 7.2 NORTH AMERICA 158
- 7.2.1 U.S. 176
- 7.2.2 OTHERS 178
- 7.3 EUROPE 180
- 7.3.1 ITALY 198
- 7.3.2 SPAIN 200
- 7.3.3 FRANCE 202
- 7.3.4 UNITED KINGDOM (U.K.) 204
- 7.3.5 GERMANY 206
- 7.3.6 OTHERS 208
- 7.4 ASIA-PACIFIC 210
- 7.4.1 JAPAN 228
- 7.4.2 CHINA 230
- 7.4.3 KOREA 232
- 7.4.4 OTHERS 234
- 7.5 REST OF THE WORLD 236
- 7.5.1 BRAZIL 253
- 7.5.2 MIDDLE EAST 255
- 7.5.3 OTHERS 256
8 COMPANY DEVELOPMENTS 258
- 8.1 INTRODUCTION 258
- 8.1.1 PRODUCT APPROVAL AS A MAJOR GROWTH STRATEGY OF
MARKET PLAYERS 258
- 8.2 PRODUCT APPROVAL 260
- 8.3 AGREEMENTS AND ACQUISITIONS 265
- 8.4 NEW PRODUCT LAUNCH 268
- 8.5 OTHER DEVELOPMENTS 270
9 MAJOR PLAYER PROFILES 272
- 9.1 BOLTON MEDICAL 272
- 9.1.1 OVERVIEW 272
- 9.1.2 FINANCIALS 273
- 9.1.3 PRODUCT PORTFOLIO 273
- 9.1.4 KEY DEVELOPMENTS 273
- 9.1.5 BUSINESS STRATEGY 274
- 9.1.6 SWOT ANALYSIS 275
- 9.2 CARDINAL HEALTH INC. 276
- 9.2.1 OVERVIEW 276
- 9.2.2 FINANCIALS 277
- 9.2.3 PRODUCT PORTFOLIO 279
- 9.2.4 KEY DEVELOPMENTS 279
- 9.2.5 BUSINESS STRATEGY 280
- 9.2.6 SWOT ANALYSIS 281
- 9.3 COOK MEDICAL, INC. 282
- 9.3.1 OVERVIEW 282
- 9.3.2 FINANCIALS 282
- 9.3.3 PRODUCT PORTFOLIO 283
- 9.3.4 KEY DEVELOPMENTS 284
- 9.3.5 BUSINESS STRATEGY 284
- 9.3.6 SWOT ANALYSIS 285
- 9.4 ENDOLOGIX, INC. 286
- 9.4.1 OVERVIEW 286
- 9.4.2 FINANCIALS 287
- 9.4.3 PRODUCT PORTFOLIO 288
- 9.4.4 KEY DEVELOPMENTS 289
- 9.4.5 BUSINESS STRATEGY 290
- 9.4.6 SWOT ANALYSIS 292
- 9.5 GETINGE GROUPS (MAQUET) 293
- 9.5.1 OVERVIEW 293
- 9.5.2 FINANCIALS 294
- 9.5.3 PRODUCT PORTFOLIO 296
- 9.5.4 KEY DEVELOPMENTS 297
- 9.5.5 BUSINESS STRATEGY 297
- 9.5.6 SWOT ANALYSIS 298
- 9.6 JOTEC GMBH 299
- 9.6.1 OVERVIEW 299
- 9.6.2 FINANCIALS 299
- 9.6.3 PRODUCT PORTFOLIO 299
- 9.6.4 KEY DEVELOPMENTS 300
- 9.6.5 BUSINESS STRATEGY 300
- 9.6.6 SWOT ANALYSIS 301
- 9.7 LIFETECH SCIENTIFIC CORPORATION. 302
- 9.7.1 OVERVIEW 302
- 9.7.2 FINANCIALS 303
- 9.7.3 PRODUCT PORTFOLIO 306
- 9.7.4 KEY DEVELOPMENTS 306
- 9.7.5 BUSINESS STRATEGY 306
- 9.7.6 SWOT ANALYSIS 307
- 9.8 LOMBARD MEDICAL TECHNOLOGIES, INC. 308
- 9.8.1 OVERVIEW 308
- 9.8.2 FINANCIALS 309
- 9.8.3 PRODUCT PORTFOLIO 309
- 9.8.4 KEY DEVELOPMENTS 310
- 9.8.5 BUSINESS STRATEGY 312
- 9.8.6 SWOT ANALYSIS 313
- 9.9 MEDTRONIC PLC 314
- 9.9.1 OVERVIEW 314
- 9.9.2 FINANCIALS 315
- 9.9.3 PRODUCT PORTFOLIO 318
- 9.9.4 KEY DEVELOPMENTS 319
- 9.9.5 BUSINESS STRATEGY 321
- 9.9.6 SWOT ANALYSIS 322
- 9.10 MICROPORT SCIENTIFIC CORPORATION 323
- 9.10.1 OVERVIEW 323
- 9.10.2 FINANCIALS 324
- 9.10.3 PRODUCT PORTFOLIO 326
- 9.10.4 KEY DEVELOPMENTS 326
- 9.10.5 BUSINESS STRATEGY 327
- 9.10.6 SWOT ANALYSIS 328
- 9.11 TERUMO CORPORATION 329
- 9.11.1 OVERVIEW 329
- 9.11.2 FINANCIALS 330
- 9.11.3 PRODUCT PORTFOLIO 332
- 9.11.4 KEY DEVELOPMENTS 333
- 9.11.5 BUSINESS STRATEGY 334
- 9.11.6 SWOT ANALYSIS 335
- 9.12 W.L. GORE & ASSOCIATES, INC. 336
- 9.12.1 OVERVIEW 336
- 9.12.2 FINANCIALS 336
- 9.12.3 PRODUCT PORTFOLIO 337
- 9.12.4 KEY DEVELOPMENTS 338
- 9.12.5 BUSINESS STRATEGY 339
Summary:
Get latest Market Research Reports on Aortic Aneurysm Repair Devices. Industry analysis & Market Report on Aortic Aneurysm Repair Devices is a syndicated market report, published as Aortic Aneurysm Repair Devices Global Market – Forecast To 2023. It is complete Research Study and Industry Analysis of Aortic Aneurysm Repair Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
